Search Results - "Coskun, B N"

Comparison of clinicodemographic characteristics and pattern of vascular involvement in 126 patients with Takayasu arteritis: a report from Iran and Turkey by Tamartash, Z, Javinani, A, Pehlivan, Y, Coskun, B N, Yekta, R A, Dalkilic, E, Yağız, B, Khavandgar, N, Pournazari, M, Hajiabbasi, A, Sakar, O, Zayeni, H, Masoleh, I S, Shakibi, M R, Yazdi, F, Mahmoudi, M, Masoumi, M, Mohammadzadegan, A M, Sima, F, Salehi, S, Faezi, S T, Jamshidi, A R, Kavosi, H

“…Takayasu arteritis (TA) is an extremely uncommon vasculitis that primarily affects the aorta and its branches. Due to the genetic and ethnicity effect, a…”
Get full text

Incident rheumatoid arthritis in patients living in Turkey and in Denmark: a comparative clinical, genetic, and serological study by Rasmussen, C, Can, G, Steffensen, R, Kenar Artin, G, Tuğsal, HY, Solmaz, D, Inanc, N, Coşkun, BN, Pehlivan, Y, Akar, S, Onen, F, Lauridsen, KB, Krogh, NS, Akkoc, N

“…The north-south gradient hypothesis proposes that individuals with rheumatoid arthritis (RA) residing in southern regions manifest a younger age of onset and…”
Get full text

Clinical and laboratory factors associated with bamboo spine in patients with axial spondyloarthritis: are there clues for bamboo spine? by Atagündüz, Pamir, Kiraz, Sedat, Akar, Servet, Küçükşahin, Orhan, Erden, Abdulsamet, Aksoy, Aysun, Coşkun, Belkis Nihan, Yağiz, Burcu, Bes, Cemal, Alpay Kanitez, Nilüfer, Kilic, Levent, Karadağ, Ömer, Kaşifoğlu, Timuçin, Emmungil, Hakan, Cinar, Muhammet, Kimyon, Gezmiş, Yazisiz, Veli, Ateş, Aşkın, Ersözlü, Duygu, Gönüllü, Emel, Mercan, Rıdvan, Ertenli, İhsan, Kalyoncu, Umut

“…To analyse the clinical and laboratory factors associated with bamboo spine. Data of patients fulfilling the 2009 ASAS classification criteria for axial…”
Get more information

Do Long-term Patient-reported Outcomes Improve Similarly in Psoriatic Arthritis and Axial Spondyloarthritis Patients Treated with Secukinumab? Results from the EuroSpA Collaboration by Pons, M, Rasmussen, SH, Christiansen, SN, Michelsen, B, Glintborg, B, Gudbjornsson, B, Grondal, GM, Vencovsky, J, Loft, AG, Rotar, Z, Pirkmajer, KP, Nissen, M, Moeller, B, Macfarlane, G, Jones, GT, Iannone, F, Caporali, RF, Laas, K, Vorobjov, S, Di Giuseppe, D, Coskun, BN, Yagiz, B, Provan, S, Fagerli, K, Castrejon, I, Otero-Valera, L, van de Sande, M, Van der Horst-Bruinsma, I, Nordstrom, D, Kuusalo, L, Vieira-Sousa, E, Bernardes, M, Olofsson, T, Baranov, J, Hetland, M, Ostergaard, M, Ornbjerg, L

Get full text

The retrospective evaluation of efficacy and safety data after switching from originator rituximab to biosimilar rituximab (CT-P10) in patients diagnosed with systemic lupus erythematosus: a single-center experience by Ekin, A, Mısırcı, S, Coşkun, B N, Yağız, B, Dalkılıç, E, Pehlivan, Y

“…In our study, we analyzed the efficacy and safety data of patients with systemic lupus erythematosus (SLE) after switching to biosimilar rituximab (RTX)…”
Get more information